Bayer Aktie News

Bayer is arguing that consumers should not be able to sue it under state law for failing to warn that Roundup increases cancer risk because the Environmental Protection Agency has found no such risk and requires no such warning.

LEVERKUSEN--(BUSINESS WIRE)--The U.S. Supreme Court today announced that it will review the Durnell Roundup™ case. Monsanto petitioned the court to hear Durnell in April 2025 and address the split in authority among federal circuit courts on the application of federal preemption, a cross-cutting issue in the Roundup™ litigation. The company expects a decision on the merits during the Court's 20...

High court gives company hope in its effort to mitigate long-running litigation that has cost it billions of dollars.

The U.S. Supreme Court agreed on Friday to hear Bayer's bid to sharply limit lawsuits claiming that the company's Roundup weedkiller causes cancer and potentially avert billions of dollars in damages.

Orion predicted strong growth for darolutamide, the prescription prostate-cancer medication it co-developed with Bayer.

Bayer DE000BAY0017 sieht die Pharmasparte wegen des Erfolgs noch junger Medikamente und geplanter Verkaufsstarts neuer Arzneien wieder auf Wachstumskurs.

The pharmaceuticals and agriculture group Bayer aims to return its pharmaceuticals business to mid-single-digit percentage growth by no later than 2027 and lift operating margins to about 30% by 2030, the division's head Stefan Oelrich said on Tuesday.

Bayer Aktiengesellschaft (BAYRY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript